Population pharmacokinetic analysis of the new oral thrombin inhibitor dabigatran etexilate (BIBR 1048) in patients undergoing primary elective total hip replacement surgery. (Q51921624)

From Wikidata

Jump to navigation Jump to search

scientific article published in March 2007

Language	Label	Description	Also known as
English	Population pharmacokinetic analysis of the new oral thrombin inhibitor dabigatran etexilate (BIBR 1048) in patients undergoing primary elective total hip replacement surgery.	scientific article published in March 2007

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17322149

Population pharmacokinetic analysis of the new oral thrombin inhibitor dabigatran etexilate (BIBR 1048) in patients undergoing primary elective total hip replacement surgery. (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17322149

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

Iñaki F. Trocóniz

1

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17322149

author name string

Christiane Tillmann

2

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17322149

Karl-Heinz Liesenfeld

3

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17322149

Hans-Günter Schäfer

4

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17322149

Joachim Stangier

5

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17322149

publication date

1 March 2007

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17322149

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17322149

47

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17322149

3

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17322149

371-382

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17322149

Management of venous thromboembolism: past, present, and future

1 reference

https://api.crossref.org/works/10.1177%2F0091270006297228

21 January 2018

Structure-based design of novel potent nonpeptide thrombin inhibitors

1 reference

https://api.crossref.org/works/10.1177%2F0091270006297228

21 January 2018

Dose escalating safety study of a new oral direct thrombin inhibitor, dabigatran etexilate, in patients undergoing total hip replacement: BISTRO I.

1 reference

https://api.crossref.org/works/10.1177%2F0091270006297228

21 January 2018

A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial.

1 reference

https://api.crossref.org/works/10.1177%2F0091270006297228

21 January 2018

Pharmacokinetic profile of the oral direct thrombin inhibitor dabigatran etexilate in healthy volunteers and patients undergoing total hip replacement

1 reference

https://api.crossref.org/works/10.1177%2F0091270006297228

21 January 2018

The importance of modeling interoccasion variability in population pharmacokinetic analyses

1 reference

https://api.crossref.org/works/10.1177%2F0091270006297228

21 January 2018

Some suggestions for measuring predictive performance

1 reference

https://api.crossref.org/works/10.1177%2F0091270006297228

21 January 2018

Pharmacokinetics of melagatran and the effect on ex vivo coagulation time in orthopaedic surgery patients receiving subcutaneous melagatran and oral ximelagatran: a population model analysis

1 reference

https://api.crossref.org/works/10.1177%2F0091270006297228

21 January 2018

Pharmacokinetics of ximelagatran and relationship to clinical response in acute deep vein thrombosis

1 reference

https://api.crossref.org/works/10.1177%2F0091270006297228

21 January 2018

Identifiers

10.1177/0091270006297228

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17322149

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17322149

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51921624&oldid=2143306171"